ICYMI: Report provides actionable recommendations to strengthen America’s preparedness and future health crises response

As America’s biopharmaceutical researchers continue working around the clock to fight COVID-19, leaders in the health care ecosystem have come together to provide recommendations to strengthen...
Read More
New initiative to bridge the gap on antimicrobial innovation

Today, more than 20 leading biopharmaceutical companies are launching the AMR Action Fund, a ground-breaking partnership to invest nearly $1 billion to ensure a robust and diverse pipeline of new...
Read More